Our results suggested that administration of CCL7 through the intranasal pathway promoted the recruitment of cDC1 into the tumor-burdened lungs and subsequent expansion of CD8+ and CD4+ T cells in the bronchial LNs and tumor-burdened lungs. The gene discussed is CD4; the disease is neoplasm.